These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22865267)

  • 1. Memory T cells are uniquely resistant to melanoma-induced suppression.
    Wentworth L; Meyers JV; Alam S; Russ AJ; Suresh M; Cho CS
    Cancer Immunol Immunother; 2013 Jan; 62(1):149-59. PubMed ID: 22865267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of T-cell expansion by melanoma is exerted on resting cells.
    Russ AJ; Wentworth L; Xu K; Rakhmilevich A; Seroogy CM; Sondel PM; Suresh M; Cho CS
    Ann Surg Oncol; 2011 Dec; 18(13):3848-57. PubMed ID: 21465311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model.
    Contreras A; Beems MV; Tatar AJ; Sen S; Srinand P; Suresh M; Luther TK; Cho CS
    J Immunother Cancer; 2018 May; 6(1):41. PubMed ID: 29843822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-induced suppression of tumor antigen-specific T cell expansion is comparable to suppression of global T cell expansion.
    Russ AJ; Xu K; Wentworth L; Alam S; Meyers JV; Macklin MD; Rakhmilevich AL; Rajamanickam V; Suresh M; Cho CS
    Cell Immunol; 2011; 271(1):104-9. PubMed ID: 21741629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
    Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
    Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts.
    Zimmerman C; Brduscha-Riem K; Blaser C; Zinkernagel RM; Pircher H
    J Exp Med; 1996 Apr; 183(4):1367-75. PubMed ID: 8666895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by
    Abu Eid R; Ahmad S; Lin Y; Webb M; Berrong Z; Shrimali R; Kumai T; Ananth S; Rodriguez PC; Celis E; Janik J; Mkrtichyan M; Khleif SN
    Cancer Res; 2017 Aug; 77(15):4135-4145. PubMed ID: 28615225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo.
    Grayson JM; Harrington LE; Lanier JG; Wherry EJ; Ahmed R
    J Immunol; 2002 Oct; 169(7):3760-70. PubMed ID: 12244170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8 T cell memory in B cell-deficient mice.
    Asano MS; Ahmed R
    J Exp Med; 1996 May; 183(5):2165-74. PubMed ID: 8642326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think.
    McDermott DS; Varga SM
    J Immunol; 2011 Dec; 187(11):5568-76. PubMed ID: 22043009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
    Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
    J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements.
    Whitmire JK; Murali-Krishna K; Altman J; Ahmed R
    Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):373-9. PubMed ID: 10794058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
    D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
    Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice.
    Homann D; Tishon A; Berger DP; Weigle WO; von Herrath MG; Oldstone MB
    J Virol; 1998 Nov; 72(11):9208-16. PubMed ID: 9765468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.
    Klebanoff CA; Gattinoni L; Palmer DC; Muranski P; Ji Y; Hinrichs CS; Borman ZA; Kerkar SP; Scott CD; Finkelstein SE; Rosenberg SA; Restifo NP
    Clin Cancer Res; 2011 Aug; 17(16):5343-52. PubMed ID: 21737507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.